Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
American adverse drug events pharmacovigilance data and novel clinical applications
The relative thrombotic risk was increased 22-fold in individuals with both abnormalities
Clarifying the Mechanism No, Mounjaro is not a blood thinner
SURMOUNT-1: Tirzepatide for Obesity The SURMOUNT-1 trial (NEJM, 2022) studied tirzepatide weight loss in 2,539 adults with obesity (without diabetes) over 72 weeks: STEP 1: Semaglutide for Obesity The STEP 1 trial (NEJM, 2021) studied semaglutide 2.4mg in 1,961 adults with obesity (without diabetes) over 68 weeks: Cross-Trial Summary Comparing across trials (with the caveat that indirect comparison has limitations): tirzepatide 15mg produced about 6 percentage points more weight loss than semaglutide 2.4mg over similar timeframes
For example, instead of 1.0 mg once weekly, you take approximately 0.43 mg every three days
US$ 22.07
US$ 26.71
US$ 22.05
US$ 20.40
US$ 29.92
US$ 27.55
US$ 27.97
US$ 22.77
